Endometrial Cancer
Endometrial Cancer
Find financial assistance programs available for endometrial (uterine) cancer drugs.
Endometrial CancerFDA Approvals, News & UpdatesImmunotherapy
In April 2021, the FDA approved Jemperli (dostarlimab-gxly) for patients with recurrent or advanced endometrial cancer and the biomarker mismatch repair-deficient. This is the first immunotherapy approved for patients with this type of cancer.
Results 1 - 3 of 3